Literature DB >> 10937152

Paroxysmal non-kinesigenic dyskinesia: pathophysiological investigations.

C T Lombroso1, A Fischman.   

Abstract

The paroxysmal dyskinesias constitute a heterogeneous group of disorders whose pathophysiologies and nosologies are still generally unknown. In a boy with severe, paroxysmal non-kinesigenic dyskinesia (PNKD), an invasive video-electrographic study demonstrated that his PNKD did not originate from the cortex, while a discharge was registered from the caudate nuclei. An 18FDG PET scan failed to show metabolic anomalies. A 18FDOPA and a 11C raclopride PET scans revealed a marked reduction in the density of presynaptic dopa decarboxylase activity in the striatum, together with an increased density of postsynaptic dopamine D2 receptors. These findings may suggest a chronic upregulation of postsynaptic dopa receptors, either because of an increase in their numbers or changes in their affinity. It remains unknown if these are secondary to reduced dopamine synthesis or altered release, or if the changes in striatal dopamine receptor binding are a primary or a compensatory mechanism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10937152

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  3 in total

1.  Antidystonic effects of Kv7 (KCNQ) channel openers in the dt sz mutant, an animal model of primary paroxysmal dystonia.

Authors:  A Richter; S E Sander; C Rundfeldt
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

Review 2.  Genetics of paroxysmal dyskinesias.

Authors:  Yvonne G Weber; Holger Lerche
Journal:  Curr Neurol Neurosci Rep       Date:  2009-05       Impact factor: 5.081

Review 3.  The clinical and genetic heterogeneity of paroxysmal dyskinesias.

Authors:  Alice R Gardiner; Fatima Jaffer; Russell C Dale; Robyn Labrum; Roberto Erro; Esther Meyer; Georgia Xiromerisiou; Maria Stamelou; Matthew Walker; Dimitri Kullmann; Tom Warner; Paul Jarman; Mike Hanna; Manju A Kurian; Kailash P Bhatia; Henry Houlden
Journal:  Brain       Date:  2015-11-23       Impact factor: 13.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.